Alternatives to PhosPrint

BICO Group is a global leader in life science solutions, enabling the bioprinting and analysis of cells, tissues, and organs.

Pioneering 3D bioprinting company developing functional human tissue models for drug discovery and regenerative medicine

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Seevix Material Sciences develops and produces SVX, a proprietary spider silk protein, for various industrial and medical applications.

Biotech company developing targeted regenerative therapeutics using a proprietary protein engineering platform for tissue repair.

Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

North American subsidiary of CTIBIOTECH, a leader in 3D bioprinting of human tissue.

A global oncology company developing and commercializing innovative cancer treatments.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Pioneering bio-engineered skin grafts for severe burns and chronic wounds.

Intero Biosystems develops human intestinal organoid platforms for drug discovery, aiming to improve preclinical testing and reduce animal reliance.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.

AI-driven drug discovery platform for rapid development of novel therapeutics.